ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers ...

The U.S. Food and Drug Administration (FDA) has classified Insulet Corporation’s recall of certain Omnipod insulin delivery ...

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod. Insulet ...

The FDA posted a notice saying the recall of Insulet's Omnipod DASH Insulin Management System Personal Diabetes Manager is a Class I, the most serious recall indicating the devices could cause serious ...

Just a few weeks after beginning a voluntary recall of the remote-control devices used with some of its insulin pumps—and warning that the safety action would take a multimillion-dollar hit to its ...

The CONTOUR ® NEXT ONE BGMS will pair, via Bluetooth Low Energy (BLE), with the Omnipod Dash™ Personal Diabetes Manager (Omnipod Dash™ PDM) to automatically transmit a person's blood glucose readings ...

The US Food and Drug Administration has cleared Insulet's Omnipod DASH Insulin Management System, a major revamp of the tubing-free insulin delivery device for use in diabetes. The Omnipod, first ...

The Omnipod DASH System has a suite of optional mobile apps for users, caregivers and HCPs to help simplify diabetes management. The Omnipod DASH System, which received FDA clearance in June 2018, is ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod ...

“We’re thrilled to bring this convenient and easy-to-use insulin delivery system to Canada,” said Bret Christensen, Chief Commercial Officer of Insulet. “The Omnipod DASH System’s sleek, touchscreen ...